Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Annick Tricot"'
Autor:
Guido J Tricot, Sarah L. Mott, Annick Tricot, Allyson Schultz, Kalyan Nadiminti, Sonya Behrends, Kamal Kant Singh Abbi, Fenghuang Zhan, Lindsay Dozeman
Publikováno v:
OncoTargets and therapy
Kalyan Nadiminti,1,2 Kamal Kant Singh Abbi,2,3 Sarah L Mott,2 Lindsay Dozeman,2 Annick Tricot,2 Allyson Schultz,2 Sonya Behrends,2,3 Fenghuang Zhan,2,3 Guido Tricot2,3 1Division of Hematology/Oncology, 2Holden Comprehensive Cancer Center, 3Department
Autor:
Lindsey Dozeman, Margarida Silverman, Matthew D. Krasowski, Umar Farooq, Guido J Tricot, Kalyan Nadiminti, Kamal Kant Singh Abbi, Annick Tricot
Publikováno v:
British journal of haematology. 174(4)
Response to treatment in patients with a plasma cell disorder is typically measured by evaluating the bone marrow and myeloma markers, including monoclonal protein spike and immunofixation (IFE) in blood and urine, and serum free light chains (sFLCs)
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:S177-S178
s / Biol Blood Marrow Transplant 22 (2016) S19eS481 S178 CMV serostatus was positive in 51 patients. Overall 23 (24.2% overall, 45.1% in seropositive patients) patients had CMV reactivation of which 11 had reactivation after first transplant, 8 after
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:S298-S299
Autor:
Sree V. Pilla, Annick Tricot, Guido J Tricot, Sarah L. Mott, Allyson Schultz, Kamal Kant Singh Abbi, Kalyan Nadiminti, Dilek Ince, Lindsay Dozeman
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S193
Autor:
Kalyan Nadiminti, Guido J Tricot, Kamal Kant Singh Abbi, Lindsay Dozeman, Sarah L. Mott, Annick Tricot, Fenghuang Zhan, Allyson Schultz
Publikováno v:
Blood. 126:1971-1971
Background: Melphalan 200mg/m2 is the standard preparative regimen in MM and addition of other cytotoxic drugs has not been found to result in superior activity. The novel agents have improved outcome in MM significantly, but data on their role in pr
Publikováno v:
Blood. 126:5435-5435
Background Autologous stem cell transplant is the standard of care for eligible multiple myeloma patients. However, many patients relapse with passage of time. These patients often do not have any or have inadequate numbers of previously harvested st
Publikováno v:
Biology of Blood and Marrow Transplantation. (2):S263
forms available from CIBMTR, as well as to enter new data while simultaneously reporting within FormsNet3. Dynamic queries were built for all commonly requested subsets of data, such as transplant volumes, mortality, engraftment, GVHD, etc. Conclusio